Latest bladder cancer Stories

Parker Waichman LLP has filed a lawsuit on behalf of a Kentucky woman who took Actos (pioglitazone) and developed bladder cancer, allegedly due to the diabetes drug. New York, New York (PRWEB) July 23, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of a Kentucky woman naming Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America,...

-Canadian launch expected in September, 2012- BELLEVILLE, ON, July 23, 2012 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that the first of two canine oncology products has received approval by regulators in both the U.S. and Canada. Market launch activities are currently underway with an expectation to have product available in September, 2012 in Canada, followed by a...

The Actos Resource Center is the Web’s largest source for information on Actos warnings, research, side effects and legal news. Visit http://www.ActosLawsuitUpdate.com Los Angeles, CA (PRWEB) July 20, 2012 The Actos Bladder Cancer Center is alerting patients who suffered side effects after taking the diabetes drug Actos that a recent order by the judge overseeing litigation may give them more time to file a claim. Legal help is still available for those just discovering they have been...

Chaffin Luhana LLP, a national plaintiffs-only law firm, alerts diabetes patients to a new study concerning Actos side effects. New York, New York (PRWEB) July 20, 2012 Chaffin Luhana LLP, a national plaintiffs-only law firm, alerts diabetes patients to a new study concerning Actos side effects. On June 15, 2011, the FDA released a safety announcement warning physicians and patients to a potential increased risk of bladder cancer in those patients taking the drug for longer than a year....

OTTAWA, July 11, 2012 /CNW/ - Health Canada has completed a thorough health risk assessment of the bladder cancer treatment ImmuCyst produced at Sanofi Pasteur's manufacturing plant in Toronto. A Health Canada inspection of Building 86 at Sanofi Pasteur's manufacturing plant in Toronto found the presence of mould in the sterile manufacturing areas where ImmuCyst was produced. Health Canada's review has concluded that ImmuCyst should remain available to bladder cancer patients,...

Connie K. Ho for redOrbit.com - Your Universe Online While grenades have been mentioned in situations related to the military, they have never been mentioned in scientific research dealing with cancer. That is, until now. A new innovative drug by researchers at the Johns Hopkins Kimmel Cancer Center, in collaboration with Danish scientists, works like a “molecular grenade”; it can move through the bloodstream until activation by specific cancer proteins. The drug is made from a...

'Molecular grenade' now in clinical trials for advanced cancer Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by specific cancer proteins. The drug, made from a weedlike plant, has been shown to destroy cancers and their direct blood supplies, acting like a "molecular grenade," and sparing healthy blood vessels and...

NEW YORK, July 9, 2012 /PRNewswire/ -- In a first-of-its kind research initiative, radical prostatectomy surgery yielded better survival rates than external beam radiation therapy (EBRT) in the treatment of localized prostate cancer. Dr. David Samadi, world-renowned SMART (Samadi Modified Advanced Robotic Technique) robotic surgeon and prostate cancer treatment expert, talks about this study of more than 1,600 men and the survival benefits of robotic prostate surgery. (Photo:...

Bernstein Liebhard LLP reports on a new study that provides further support regarding the Actos bladder cancer link. New York, NY (PRWEB) July 06, 2012 Bernstein Liebhard LLP, a nationwide law firm representing clients who have been injured by dangerous drugs and defective medical devices, reports on a July 3, 2012 study published in the Canadian Medical Association Journal, which found that patients taking Actos face a 22 percent increased risk of bladder cancer.* In conducting the...

(Ivanhoe Newswire) -- Injections, blood sugar awareness, and constant finger pricking--these are all things someone who suffers from type-2 diabetes has to deal with. Researchers say, now they may have to worry about bladder cancer, too. An increased risk of bladder cancer is linked to the use of pioglitazone (a type of thiazolidinedione), a medication commonly used to treat type-2 diabetes. People with type-2 diabetes are at risk of several types of cancer, including a 40% increased risk...